The official blog of the Lung Institute.

What is Coal Worker’s Pneumoconiosis?

What is Coal Workers Pneumoconiosis

Coal worker’s pneumoconiosis, also known as black lung disease, is an occupational lung condition that most commonly affects miners and other workers who have inhaled coal dust for an extended period of time. This interstitial lung disease occurs when dust from graphite, coal or man-made carbon builds up in the lungs over time and the lungs become visibly blackened. This dust buildup in the lungs can lead to extensive damage, including injury to the walls of the air sacs which then inhibit the exchange oxygen for carbon dioxide, a stiffening of the lungs that decreases the lungs’ ability to expand with oxygen, and very poor lung function in general.

There are two forms of coal worker’s pneumoconiosis:

  • Simple coal worker’s pneumoconiosis — Because this is the early form of the disease, there may be very few symptoms, if any. It is often characterized by clusters of nodules within the lungs that have formed where the coal dust has built up.
  • Progressive massive fibrosis — When exposure to coal dust is prolonged, the disease can progress to the development of massive fibrosis in the lungs, which greatly affects lung function.

Symptoms of coal worker’s pneumoconiosis vary from person to person but most often include shortness of breath, chronic cough, increased mucus production, pulmonary hypertension and decreased lung function. The severity of this condition is dependent upon how long an individual was exposed to the dust and the amount of coal dust that was inhaled during that time.

The treatment approach for a patient with this lung disease will depend on the patient’s particular symptoms and how far the condition has progressed. Common traditional treatment options include medication aimed at keeping the airways open and reducing mucus production, oxygen therapy and pulmonary rehabilitation. If you haven’t been able to find relief through these conservative methods, the Lung Institute offers an innovative treatment solution for coal worker’s pneumoconiosis through stem cell therapy. Unlike many other options that only address the symptoms of the disease, stem cell therapy has been proven to potentially slow the progression of black lung disease, increase lung function and improve a patient’s quality of life.

If you’ve been diagnosed with coal worker’s pneumoconiosis and would like to explore alternative and natural treatment options that could help you find relief from your symptoms, call the Lung Institute today at (800) 729-3065 to learn more about our stem cell therapy treatment.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.